BPD Biologics Process Development Conference Singapore — Expanding into the Southeast Asian Market
Meeting Overview
Highlights
- •Leverage craftsmanship and production capacity to unlock market potential in Asia-Pacific, particularly Southeast Asia.
Forum Agenda Framework
BPD & XDC Gala Dinner
BPD & XDC Gala Dinner
BPD Plenary Forum (Session 1)
Welcome
Vera Deng, Enmore BIO, Founder & CEO
Opening Remarks
Jimmy Li, WuXi XDC, CEO
Dialogue: A New Paradigm for the Globalization of China's Biopharmaceutical Industry
Chris Chen, WuXi Biologics, CEO
Panel Discussion: Cross-Border Synergy and Joint Bilateral Development
Jimmy Li, CEO, WuXi XDC | Bo Ying, CEO, Abogen Biosciences | Tony Xue, Founder & CEO, MediLinkTherapeutics
Tea Break & Networking
Keynote: Strategic Framework for Chinese Pharmaceutical Companies Entering Southeast Asia
Clement Yau, Temasek LifeSciences Accelerator, Vice President, Investments
Panel: From Partnership to Value Co-Creation
Moderator: Clement Yau | Lawrence, CEO of Rxilient | Pengfei Chen, VP at EDB | Shri Sarkar, Partner at L.E.K. Consulting
Lunch & Networking
Session 1 — Novel Molecules and Innovative Therapeutics
XDC
BsAb-TCE
XDC & BsAb-TCE: Global Development and Regulatory Compliance
Cell Therapy
Session 2 — Regulation and Market Access in Southeast Asia
Indonesia
Saudi Arabia
Singapore
Thailand
Thermo Fisher Session
Delivering Results in Upstream Bioprocessing: From Stable Cell Lines to Scalable Manufacturing
Activities
BPD Partnering
BPD Partnering
Closed-Door Meeting: Chinese Pharmaceutical Companies Expanding Globally
BPD Partnering
Session 1 — Cell Therapy
Cell Therapy
Session 1 — AI for Pharma
AI for Pharmaceuticals
Session 2 — Cooperation Opportunities in Southeast Asia
Southeast Asia Cooperation Opportunities
India
Malaysia
Activities
BPD Partnering
BPD Partnering
Session 1 — Advanced Technology
Advanced Technology
Session 3 — Small Nucleic Acids / Peptides / mRNA / Gene Therapy
Small Nucleic Acids / Peptides / mRNA / Gene Therapy
Activities
BPD Partnering
Special Guest
Shanti Marlina
POM Agency
Director of Drug, Narcotic, Psychotropic, and Precursor Production Control (Acting)
H. Fai Poon
CEO
Sirnaomics
Haisheng Zhang
Founder & CEO
Signet Therapeutics
Andre Choo
Deputy Executive Director
BTI, A*STAR
Yi Yan YANG
Distinguished Principal Scientist
BTI, A*STAR
Gang Qin
CEO
Gene Quantum
Poh Jeff
Regulatory Affairs CMC Lead
Gilead Sciences
Junita Dwi Andhini
QA Engineering
PT Bio Farma
Liu Dou
CEO
Oralead Pharma
Veerachat Petpisit
CEO
Nouvogenes Therapeutics
Vince Deng
Partner
Med-Fine Capital
Shri Sarkar
Partner
L.E.K. Consulting
Abdulaziz AlSayyari
Managing Partner
BiSynergic
Zhang Wei
Group Leader, Principal Scientist
BTI, A*STAR
Jin Shun
Managing Director
PharmaGend Consulting Pte Ltd
Vipul Doshi
Chief Quality and Compliance Officer, Global Head of Pharmacovigilance
Zydus Lifesciences Limited
Shanti Marlina
POM Agency
Director of Drug, Narcotic, Psychotropic, and Precursor Production Control (Acting)
H. Fai Poon
CEO
Sirnaomics
Haisheng Zhang
Founder & CEO
Signet Therapeutics
Andre Choo
Deputy Executive Director
BTI, A*STAR
Yi Yan YANG
Distinguished Principal Scientist
BTI, A*STAR
Gang Qin
CEO
Gene Quantum
Poh Jeff
Regulatory Affairs CMC Lead
Gilead Sciences
Junita Dwi Andhini
QA Engineering
PT Bio Farma
Liu Dou
CEO
Oralead Pharma
Veerachat Petpisit
CEO
Nouvogenes Therapeutics
Vince Deng
Partner
Med-Fine Capital
Shri Sarkar
Partner
L.E.K. Consulting
Abdulaziz AlSayyari
Managing Partner
BiSynergic
Zhang Wei
Group Leader, Principal Scientist
BTI, A*STAR
Jin Shun
Managing Director
PharmaGend Consulting Pte Ltd
Vipul Doshi
Chief Quality and Compliance Officer, Global Head of Pharmacovigilance
Zydus Lifesciences Limited
Ling Tong
BD VP/Head
Buchang BioPharma
Daniel Lee
Head of Commercial
Menarini APAC
Zhenbo Su
CEO
TCRCure Biological Technology
Lipeng Lai
Co-Founder & CIO
XtalPi
Ting He
CEO
IMUNOPHARM Technology
Jing Fan
Founder & CEO
Hopstem Therapeutics
Jun Feng
APAC Market Access Director
Johnson & Johnson
Claire Zhang
Chief Technology Officer
Gritgen
Yen CHOO
Associate Professor of Stem Cell Science and Regenerative Medicine
NTU Lee Kong Chian School of Medicine
Gaurav Arora
Chief Compliance Officer
BioPharma Center
Audrey Jia
Founder of Wonderfulland Regulatory Consulting
ex-FDA OBP CMC Reviewer
Vijay P. Karwal
Managing Director
CBC Group
Bo Ying
CEO
Abogen Biosciences
Xiaoming PENG
CEO
Lion TCR
Lalit Baregama
CBO
Symbiotec Pharmalab
Ling Tong
BD VP/Head
Buchang BioPharma
Daniel Lee
Head of Commercial
Menarini APAC
Zhenbo Su
CEO
TCRCure Biological Technology
Lipeng Lai
Co-Founder & CIO
XtalPi
Ting He
CEO
IMUNOPHARM Technology
Jing Fan
Founder & CEO
Hopstem Therapeutics
Jun Feng
APAC Market Access Director
Johnson & Johnson
Claire Zhang
Chief Technology Officer
Gritgen
Yen CHOO
Associate Professor of Stem Cell Science and Regenerative Medicine
NTU Lee Kong Chian School of Medicine
Gaurav Arora
Chief Compliance Officer
BioPharma Center
Audrey Jia
Founder of Wonderfulland Regulatory Consulting
ex-FDA OBP CMC Reviewer
Vijay P. Karwal
Managing Director
CBC Group
Bo Ying
CEO
Abogen Biosciences
Xiaoming PENG
CEO
Lion TCR
Lalit Baregama
CBO
Symbiotec Pharmalab
